Your browser doesn't support javascript.
loading
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding.
Massó-Vallés, Daniel; Beaulieu, Marie-Eve; Jauset, Toni; Giuntini, Fabio; Zacarías-Fluck, Mariano F; Foradada, Laia; Martínez-Martín, Sandra; Serrano, Erika; Martín-Fernández, Génesis; Casacuberta-Serra, Sílvia; Castillo Cano, Virginia; Kaur, Jastrinjan; López-Estévez, Sergio; Morcillo, Miguel Ángel; Alzrigat, Mohammad; Mahmoud, Loay; Luque-García, Antonio; Escorihuela, Marta; Guzman, Marta; Arribas, Joaquín; Serra, Violeta; Larsson, Lars-Gunnar; Whitfield, Jonathan R; Soucek, Laura.
Afiliación
  • Massó-Vallés D; Preclinical & Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, Barcelona, Spain.
  • Beaulieu ME; Peptomyc S.L., Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Jauset T; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Giuntini F; Preclinical & Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, Barcelona, Spain.
  • Zacarías-Fluck MF; Peptomyc S.L., Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Foradada L; Preclinical & Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, Barcelona, Spain.
  • Martínez-Martín S; Peptomyc S.L., Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Serrano E; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Martín-Fernández G; Preclinical & Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, Barcelona, Spain.
  • Casacuberta-Serra S; Preclinical & Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, Barcelona, Spain.
  • Castillo Cano V; Peptomyc S.L., Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Kaur J; Preclinical & Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, Barcelona, Spain.
  • López-Estévez S; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Morcillo MÁ; Preclinical & Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, Barcelona, Spain.
  • Alzrigat M; Preclinical & Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, Barcelona, Spain.
  • Mahmoud L; Peptomyc S.L., Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Luque-García A; Peptomyc S.L., Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Escorihuela M; Preclinical & Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, Barcelona, Spain.
  • Guzman M; Peptomyc S.L., Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Arribas J; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.
  • Serra V; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.
  • Larsson LG; Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.
  • Whitfield JR; Preclinical & Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, Barcelona, Spain.
  • Soucek L; Preclinical & Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, Barcelona, Spain.
Cancer Res Commun ; 2(2): 110-130, 2022 02.
Article en En | MEDLINE | ID: mdl-36860495
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Animals / Humans Idioma: En Revista: Cancer Res Commun Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Animals / Humans Idioma: En Revista: Cancer Res Commun Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos